Breast cancer not linked to bras
the ONA take:
According to a new study published in Cancer Epidemiology, Biomarkers, and Prevention, wearing bras does not increase a woman's risk for developing breast cancer. In the study, researchers identified more than 1,000 postmenopausal women with invasive breast cancer and about 450 women without cancer.
Among other things, women were asked about their lifetime patterns of bra use during face-to-face interviews. Researchers analyzed the data and found that there was no association between bra use and the development of breast cancer.
There has previously been no data indicating that wearing a bra is linked to developing breast cancer, but a book entitled "Dressed to Kill: The Link Between Breast Cancer and Bras," which was published in 1995, started the widespread rumors that there is an association. The book proposed that women of Western cultures had an increased risk of breast cancer compared with indigenous cultures because Western women wear bras. The study was widely criticized for its poor study design.
This new case-control study conducted by the Fred Hutchinson Cancer Research Center in Seattle, Washington, now puts to rest the myths surrounding wearing bras and developing breast cancer.
Wearing bras does not increase a woman's risk for developing breast cancer.
It's official, you can wear a bra without increasing your risk of developing breast cancer. Despite there being no scientifically valid data indicating that wearing a bra causes cancer, there have been widespread rumours to the contrary.
They were started in 1995 by the book “Dressed to Kill: The Link Between Breast Cancer and Bras,” The authors suggested that the increased risk of breast cancer in Western cultures compared with indigenous cultures was due to wearing bras. However, the research methodology was criticized for having a range of design flaws, including not adjusting for known breast cancer risks such as weight and age, but Western women continued to worry.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|